We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
News in brief.
- Abstract
The article offers news briefs related to law and policy in medicine. The biotech company Geron Corp. announced on January 23, 2009 that it received approval from the Food and Drug Administration (FDA) to test a therapy based on human embryonic stem cells. On February 6, 2009, FDA approved the first drug antithrombin produced by transgenic livestock. President Barack Obama signed an economic recovery bill to support biomedical research and improve facilities over the next two years.
- Subjects
UNITED States; MEDICAL laws; UNITED States. Food &; Drug Administration; EMBRYONIC stem cells; GERON Corp.; OBAMA, Barack, 1961-; MEDICAL research laws
- Publication
Nature Medicine, 2009, Vol 15, Issue 3, p228
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm0309-228